Innate Pharma S.A. (IPHA)
undefined
undefined%
At close: undefined
3.00
-1.80%
After-hours Dec 13, 2024, 07:59 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Net Income -7.57M -58.10M -52.81M -63.98M -20.76M 3.05M -48.38M 12.64M -6.71M -19.65M -2.89M -3.20M -6.98M -13.66M -14.63M -9.85M -8.92M -6.04M -6.13M
Depreciation & Amortization 5.09M 45.41M 4.60M 56.80M 16.53M 7.40M 4.39M 3.26M 2.65M 2.34M 880.00K 839.00K 901.00K 1.10M 1.02M 539.00K 536.00K 298.00K 301.00K
Stock-Based Compensation 4.26M 4.25M 2.62M 2.48M 3.83M 2.71M 9.83M 1.03M 1.01M 377.00K 325.00K - 219.00K 35.00K 1.77M 1.34M 1.26M 1.19M 214.00K
Other Working Capital -28.20M -636.00K -6.06M -45.14M 38.86M -47.10M -16.98M -58.68M 202.26M -883.00K -4.27M -7.52M - - - - - - -
Other Non-Cash Items -2.24M 1.80M -1.29M -544.00K -774.00K 253.00K -88.00K -383.00K 47.00K 170.00K 144.00K 444.00K -274.00K -1K -1.95M 857.00K 111.00K 1K -1.64M
Deferred Income Tax - - -1.68M 2.65M -4.14M 1.16M 3.17M -2.61M -586.00K -78.00K -9.00K - - -259.00K 1.06M - - 49.00K 1.64M
Change in Working Capital -32.09M -12.50M -9.88M -49.20M 40.25M -47.10M -16.98M -50.79M 211.49M -1.30M -9.41M -8.56M 19.12M -666.00K 6.78M -7.63M -2.27M 4.87M -1.64M
Operating Cash Flow -32.56M -19.15M -58.46M -51.81M 34.92M -32.53M -48.06M -36.85M 207.91M -18.13M -10.97M -10.47M 12.99M -13.45M -5.94M -14.74M -9.28M 360.00K -7.25M
Capital Expenditures -2.35M -1.12M -1.33M -11.28M -65.40M -1.43M -6.03M -9.39M -7.40M -2.34M -433.00K -1.23M -322.00K -408.00K -511.00K -1.90M -1.30M -752.00K -112.00K
Acquisitions - - 7.00K 9.00K - 22.00K 3.06M 8.04M - -60.00K -120.00K - - - - 375.00K - - -
Purchase of Investments - - - -3.00M - - -43.27M -18.15M -121.87M -1.96M -3.00M -2.03M - - -549.00K -15.91M - -99.45M -5.36M
Sales Maturities Of Investments 22.77M 3.00M - -9.00K 2.00M 25.66M 19.84M 88.06M 6.97M 541.00K 2.48M - 2.77M - 20.00M 41.46M 5.97M 61.21M 4.04M
Other Investing Acitivies -1.79M -1K 406.00K 912.00K 1.28M 46.00K -3.06M -8.04M 972.00K 2.00K 115.00K -154.00K - 119.00K - -1.50M 304.00K - -
Investing Cash Flow 20.63M 1.88M -917.00K -13.37M -62.12M 24.28M -29.46M 60.51M -122.30M -3.82M -958.00K -3.41M 2.44M -289.00K 18.94M 22.52M 4.97M -38.99M -1.43M
Debt Repayment -2.36M -2.03M 26.63M -885.00K 11.92M -1.34M 537.00K -685.00K -452.00K -613.00K 314.00K -2.26M -719.00K -789.00K -257.00K 623.00K 339.00K 712.00K 249.00K
Common Stock Repurchased - - - - - - - - - -70.00K - - - -112.00K -300.00K - - - -
Dividend Paid - - - - - - - - - -850.00K - - - - -1.20M - - - -
Other Financial Acitivies 395.00K - 188.00K -251.00K -159.00K 8.00K 378.00K 69.00K 3.36M 1.70M 278.00K - 36.00K - 1.20M - -1K 1K -
Financial Cash Flow -1.97M -1.83M 26.82M -1.14M 77.77M 61.22M 915.00K -602.00K 3.03M 47.95M 19.68M -2.15M -659.00K -893.00K 22.56M 623.00K 631.00K 42.21M 249.00K
Net Cash Flow -13.62M -19.53M -33.04M -66.09M 50.57M 52.95M -76.54M 23.04M 88.58M 25.93M 7.78M -16.02M 14.79M -14.63M 35.56M 8.40M -3.68M 3.57M -8.43M
Free Cash Flow -34.91M -20.28M -59.79M -63.09M -30.48M -33.96M -54.09M -46.24M 200.51M -20.48M -11.40M -11.70M 12.66M -13.86M -6.45M -16.64M -10.58M -392.00K -7.36M